Helen of Troy Limited

Helen of Troy Limited (HELE) Market Cap

Helen of Troy Limited has a market capitalization of $643.6M.

Price: $27.63

ā–¼ -0.25 (-0.90%)

Market Cap: 643.56M

NASDAQ Ā· time unavailable

CEO: George Scott Uzzell

Sector: Consumer Defensive

Industry: Household & Personal Products

IPO Date: 1976-07-08

Website: https://www.helenoftroy.com

Helen of Troy Limited (HELE) - Company Information

Market Cap: 643.56M|Sector: Consumer Defensive

Company Profile

Helen of Troy Limited is a global consumer products enterprise that markets a diverse array of goods across the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. The company's operations are structured into three primary divisions: Home & Outdoor, Health & Wellness, and Beauty. The Home & Outdoor segment provides a variety of household essentials, including kitchen tools, storage and organization solutions, cleaning items, baby feeding and nursery products, insulated drinkware and food containers, and technical outdoor gear like backpacks and luggage. Within the Health & Wellness segment, offerings include health monitoring devices such as thermometers and blood pressure monitors, air quality appliances like purifiers, heaters, and humidifiers, and water purification systems. The Beauty division focuses on hair care, supplying grooming brushes, styling tools, decorative accessories, and a range of shampoos, conditioners, and styling products. Helen of Troy distributes its products through an extensive network that encompasses mass merchandisers, drugstore chains, warehouse clubs, home improvement centers, grocery stores, specialty retailers, beauty supply outlets, e-commerce platforms, wholesalers, and various distributors, in addition to direct-to-consumer sales. Notable brands under its umbrella include OXO, Hydro Flask, Osprey, PUR, Honeywell, Braun, Vicks, Drybar, Hot Tools, Revlon, and Bed Head. Incorporated in 1968, the company is headquartered in El Paso, Texas.

Analyst Sentiment

63%
Buy

From 4 Active Polls

1Y Forecast: $26.50

ā–¼ -4.1% Potential Upside

Consensus Target Metrics

Low Bound

$25

Median

$27

High Bound

$28

Average

$27

Price & Moving Averages

Loading chart...

šŸŽÆ Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$26.50
ā–¼ -4.09% Upside
Low Target
$25.00
-10% Risk
Median Target
$26.50
-4% Mid
High Target
$28.00
1% Max
Consensus
Hold
3 / 11 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

šŸ“Š Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MMay 31, 2026Feb 28, 2026Nov 30, 2025Aug 31, 2025May 31, 2025Feb 28, 2025Nov 30, 2024Aug 31, 2024
Market Cap ($M)6446334064515646171,2601,6771,227
Enterprise Value ($M)1,3931,3831,2211,3701,4741,5062,1982,4111,957
Price to Earnings Ratio (P/E)-1.544.41-1.83-1.34-0.46-0.346.208.4517.79
Price/Earnings-to-Growth Ratio (PEG)———-0.07-0.03——0.711.29
Price to Sales Ratio (P/S)0.351.580.860.881.311.662.593.162.59
Price to Book Ratio (P/B)0.780.750.510.530.610.500.751.030.78
Price to Free Cash Flow Ratio (P/FCF)8.00-98.325.1878.07194.9013.7146.588778.3030.91
Enterprise Value to Sales (EV/Sales)—3.442.602.673.414.054.524.544.13
Enterprise Value to EBITDA (EV/EBITDA)-5.3318.70-32.79292.93-4.8776.3327.7125.8539.49
Debt to Equity Ratio-2.870.911.041.111.010.740.570.480.48

šŸ“˜ Full Research Report

ā„¹ļø

AI-Generated Research: This report is for informational purposes only.

šŸ“˜ HELEN OF TROY LTD (HELE) — Investment Overview

🧩 Business Model Overview

Helen of Troy is a consumer products and consumer health brand owner and operator. The company designs and markets products across consumer health/household wellness categories and everyday home and lifestyle items (including branded drinkware and home goods). The operating model typically relies on third-party manufacturing, with in-house emphasis on product development, brand management, and go-to-market execution. Products flow from sourcing and manufacturing through distribution to major retail channels and e-commerce, supported by merchandising, packaging, and channel-specific programs that sustain shelf presence and reorder behavior in consumable categories.

šŸ’° Revenue Streams & Monetisation Model

Revenue is primarily driven by branded product sales, with monetisation coming through (1) repeat purchasing in health and wellness-related consumables/accessories and (2) point-in-time purchases in durable categories such as drinkware and home goods. Margin drivers are shaped by brand pricing power, promotional intensity by channel, freight and input costs (metals/resins/packaging), and manufacturing/outsourcing terms. Higher-quality brand positioning and differentiated product design tend to support better gross margins, while scale in procurement and logistics helps stabilize unit economics across product cycles. Working-capital efficiency matters because consumer product demand can shift quickly across seasons and retail inventory cycles.

🧠 Competitive Advantages & Market Positioning

HELE’s moat is best characterized as an Intangible Asset + Distribution/Programmatic Advantage combination rather than a technology lock-in. The company’s long-lived brand portfolio, trademarked designs, and category-specific product innovation create real but competitive (rather than absolute) protection. For many SKUs, consumers and retailers build habit and merchandising continuity over time, which can reduce effective ā€œswitchingā€ and raise the cost of displacing an established assortment. Retailers also benefit from predictable performance from proven brands, supporting shelf/planogram persistence and promotional planning.

  • Intangible assets (brands, product design, IP/trademarks): strengthens pricing and protects assortment longevity.
  • Channel execution and retailer relationships: improves forecastability of sell-in/sell-through and supports programmatic marketing.
  • Scale in sourcing and logistics: offsets cost inflation and helps maintain competitiveness across cycles.

Competitive benchmarking: In consumer health/OTC-adjacent wellness and personal care, competitors include Procter & Gamble (P&G) and Reckitt, which leverage deep category research, broad distribution, and large OTC/pharma-adjacent portfolios. In drinkware and lifestyle products, competitors include YETI and Stanley, which emphasize premium brand identity and strong distribution momentum.

Compared with these rivals, HELE is more diversified across health/wellness accessories and home/lifestyle categories, which can reduce dependence on a single end market. This diversification also supports internal learning across product development, packaging, and channel strategy, while brand-level leadership varies by category rather than relying on a single flagship franchise.

šŸš€ Multi-Year Growth Drivers

  • Assortment expansion and product refresh cycles: durable categories (drinkware/home goods) and wellness accessories both benefit from iterative upgrades, new styles, and retailer-supported seasonal programs.
  • E-commerce and direct-to-consumer channel mix: branded products with clear differentiation can sustain online conversion through content, bundling, and merchandising.
  • Category participation in ā€œwellness at homeā€: household health routines and personal care demand can provide structural tailwinds versus purely discretionary goods.
  • Operating leverage from stable brand demand: when pricing discipline and promotional cadence hold, gross margin and overhead absorption improve as volumes scale.
  • M&A and brand acquisition discipline: brand portfolios can be supplemented when acquisition targets offer distributable products with identifiable cost and merchandising improvements.

⚠ Risk Factors to Monitor

  • Retail inventory and promotional intensity: consumer cycles can compress sell-through, increasing markdowns and working-capital strain.
  • Input cost volatility: metals, resins, packaging, and freight can pressure gross margins if pricing cannot keep pace.
  • Brand concentration or category underperformance: performance may diverge by brand/category, requiring continuous innovation to maintain relevance.
  • Regulatory and compliance exposure: consumer health-related products can face evolving labeling, claims substantiation, and safety requirements.
  • Manufacturing and supply continuity: reliance on outsourced production heightens risk around quality, lead times, and execution during demand swings.
  • Competitive displacement: premium lifestyle brands and major consumer staples firms can apply significant promotional and distribution resources to defend or expand share.

šŸ“Š Valuation & Market View

Markets often value diversified branded consumer product companies like HELE using EV/EBITDA and earnings-based multiples, with price-to-sales used when near-term earnings visibility is pressured by promotional cycles or input-cost moves. The valuation ā€œneedleā€ typically responds to:

  • Normalized margin profile (gross margin resilience and the ability to manage promotional cadence).
  • Free cash flow conversion (working-capital discipline and capex efficiency).
  • Consistency of demand across seasonal peaks and channel mix.
  • Credible growth strategy tied to measurable assortment expansion and channel execution rather than one-off product spikes.

šŸ” Investment Takeaway

HELE’s long-term appeal rests on a diversified portfolio of branded consumer and wellness-related products, supported by intangible assets, assortment stickiness, and channel execution that can sustain earnings power through product cycles. The investment thesis is best viewed as a brand-and-distribution compounder: durable categories with repeat purchase elements can stabilize the model, while continued innovation and operational leverage can support multi-year growth—provided promotional intensity, input costs, and working capital remain managed within tolerances.


⚠ AI-generated — informational only. Validate using filings before investing.

šŸ“° Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for HELE.

globenewswire.com•2026-07-31

HELEN OF TROY DEADLINE MONDAY AUGUST 3rd: Bragar Eagel & Squire, P.C. Reminds Helen of Troy Limited Investors That Class Action Lawsuit Has Been Filed and Urges Investors to Contact the Firm Before August 3rd

Bragar Eagel and Squire, P. C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Helen of Troy (HELE) To Contact Him Directly To Discuss Their Options If you purchased or acquired Helen of Troy common stock between April 24, 2024, and October 8, 2025 and would like to discuss your legal rights, contact Bragar Eagel and Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.

globenewswire.com•2026-07-31

HELEN OF TROY DEADLINE MONDAY AUGUST 3rd: Bragar Eagel & Squire, P.C. Reminds Helen of Troy Limited Investors That Class Action Lawsuit Has Been Filed and Urges Investors to Contact the Firm Before August 3rd

Bragar Eagel & Squire, P.C.Ā  Litigation PartnerĀ  Brandon Walker Ā Encourages Investors Who Suffered Losses In Helen of Troy (HELE) To Contact Him Directly To Discuss Their Options

globenewswire.com•2026-07-31

HELE DEADLINE: The Gross Law Firm Reminds Helen of Troy Limited Investors of Upcoming Securities Class Action Deadline

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Helen of Troy Limited (NASDAQ: HELE).

globenewswire.com•2026-07-31

HELE DEADLINE: The Gross Law Firm Reminds Helen of Troy Limited Investors of Upcoming Securities Class Action Deadline

NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Helen of Troy Limited (NASDAQ: HELE). Shareholders who purchased shares of HELE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

globenewswire.com•2026-07-30

Bronstein, Gewirtz & Grossman LLC Urges Helen of Troy Limited Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Helen of Troy (HELE) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 8/3/2026

globenewswire.com•2026-07-30

Bronstein, Gewirtz & Grossman LLC Urges Helen of Troy Limited Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Helen of Troy Limited (NASDAQ: HELE) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Helen of Troy securities between April 24, 2024 and October 8, 2025, both dates inclusive (the "Class Period").

feeds.newsfilecorp.com•2026-07-30

Bronstein, Gewirtz & Grossman LLC Urges Helen of Troy Limited Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - July 30, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law

globenewswire.com•2026-07-28

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Helen of Troy Limited of Class Action Lawsuit and Upcoming Deadlines – HELE

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Helen of Troy Limited (ā€œHelen of Troyā€ or the ā€œCompanyā€) (NASDAQ: HELE).   Such investors are advised to contact Danielle Peyton atĀ  [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

globenewswire.com•2026-07-28

Portnoy Law Firm Announces Class Action on Behalf of Helen of Troy Limted Investors

LOS ANGELES, July 28, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advisesĀ Helen of Troy Limited, (ā€œHelen of Troyā€ or the "Company") (NASDAQ: HELE) investors of a class action on behalf of investors that bought securities between May 13, 2025 and February 19, 2026, inclusive (the ā€œClass Periodā€). Helen of Troy investors have until August 4, 2026 to file a lead plaintiff motion.

prnewswire.com•2026-07-28

HELE Shareholder Alert: Helen of Troy Limited Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

NEW YORK, July 28, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders ofĀ Helen of Troy Limited (NASDAQ: HELE). Shareholders who purchased shares of HELE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

globenewswire.com•2026-07-27

Bragar Eagel & Squire, P.C. Reminds Helen of Troy Limited Investors That Class Action Lawsuit Has Been Filed and Encourages Urges to Contact the Firm Before August 3rd

Bragar Eagel & Squire, P.C.Ā  Litigation PartnerĀ  Brandon Walker Ā Encourages Investors Who Suffered Losses In Helen of Troy (HELE) To Contact Him Directly To Discuss Their Options

newsfilecorp.com•2026-07-27

Bronstein, Gewirtz & Grossman LLC Urges Helen of Troy Limited Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - July 27, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Helen of Troy Limited (NASDAQ: HELE) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Helen of Troy securities between April 24, 2024 and October 8, 2025, both dates inclusive (the "Class Period").

newsfilecorp.com•2026-07-24

Bronstein, Gewirtz & Grossman LLC Urges Helen of Troy Limited Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - July 24, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Helen of Troy Limited (NASDAQ: HELE) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Helen of Troy securities between April 24, 2024 and October 8, 2025, both dates inclusive (the "Class Period").

globenewswire.com•2026-07-24

HELE Investors are Reminded of the Pending Lead Plaintiff Deadline on August 3, 2026; Contact Robbins LLP for Information About Recovering Your Losses

SAN DIEGO, July 24, 2026 (GLOBE NEWSWIRE) -- Robbins LLPĀ reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Helen of Troy Limited (NASDAQ: HELE) common stock between April 24, 2024 and October 8, 2025. Helen of Troy markets a variety of consumer goods across several segments.

globenewswire.com•2026-07-23

Bronstein, Gewirtz & Grossman LLC Urges Helen of Troy Limited Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Helen of Troy Limited (NASDAQ: HELE) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Helen of Troy securities between April 24, 2024 and October 8, 2025, both dates inclusive (the ā€œClass Periodā€).

šŸ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-05-31

"Headline (2026-05-31, Q1): Revenue $402.1M, EPS $1.51, Net income $35.8M (net margin 8.9%). QoQ: Revenue -14.5% (vs $470.0M in 2026-02-28). Net income flipped from -$55.6M (loss) in Q4 to +$35.8M in Q1. YoY: Revenue +8.1% (vs $371.7M in 2025-05-31) and Net income turned from -$450.7M in Q1 last year to +$35.8M this quarter. Profitability improved meaningfully: operating margin rose to 15.0% from 6.0% QoQ and moved from deeply negative last year (Q1 2025 operating margin -109.5%). Gross margin also improved slightly to 46.0% (vs 44.6% QoQ and 47.1% YoY), indicating stronger cost discipline and/or fewer non-operating drags. Cash flow quality remains mixed: operating cash flow was -$0.6M and free cash flow -$6.4M in Q1, contrasting with strong Q4 OCF (+$111.3M). Balance sheet resilience improved on a headline basis: equity rose sharply to $1.78B from $0.80B QoQ, while net debt remains high at ~$775M. Shareholder returns were weak on market momentum (1Y change -42.8%) with no dividend noted (dividend yield 0% and dividends paid 0). Valuation context shows modest upside to consensus targets (target $22 vs $18.86 current), but the total-return setup is currently constrained by the negative price trend."

Revenue Growth

Neutral

YoY Revenue +8.1% ($402.1M vs $371.7M). QoQ Revenue -14.5% ($402.1M vs $470.0M), indicating short-term deceleration.

Profitability

Good

Net income turned positive to $35.8M from -$55.6M QoQ and from -$450.7M YoY. Operating margin improved to 15.0% (from 6.0% QoQ; -109.5% YoY), signaling margin expansion.

Cash Flow Quality

Neutral

Despite profits, Q1 operating cash flow was -$0.6M and free cash flow -$6.4M. This weak conversion contrasts with Q4 OCF (+$111.3M), reducing cash-flow confidence.

Leverage & Balance Sheet

Fair

Equity rose to $1.78B QoQ (from $0.80B), improving stated resilience. Net debt remains elevated at ~$775M, with debt not meaningfully reduced QoQ.

Shareholder Returns

Neutral

Total shareholder return pressure from price momentum: 1Y change -42.8% and no dividend/dividend payments (yield 0%). Buybacks were small (repurchased -$1.2M vs equity scale).

Analyst Sentiment & Valuation

Neutral

Consensus target $22 vs $18.86 current implies upside (~16.6%). However, negative 1-year price trend suggests sentiment has not fully re-rated yet.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

HELE delivered a strong Q1 beat (net sales +8.2% above expectations) with upside partially explained by ~$4m–$5m Prime Day order phasing and a ~$1.8m pre-tax tariff refund benefit (phase one). However, profitability deteriorated: gross margin fell 110 bps to 46% and adjusted operating margin fell 30 bps to 4%, reflecting tariff effects, mix, and higher go-to-market/people investment. Management raised full-year sales to $1.759b–$1.831b and held adjusted EPS at $3.25–$3.75, but guided full-year cost inflation assumptions that exceed the ~9.2m phase I refund benefit. They explicitly do not assume future tariff refund phases in base guidance and highlighted risk from geopolitical/supply-chain disruptions and cautious retailer behavior. Operationally, they’re retooling around an ā€œoffenseā€ model with dedicated segment GMs and geo GMs to tighten decision-making, improve e-commerce/demand planning, and maintain pricing discipline despite elasticity watchpoints.

AI IconGrowth Catalysts

  • Osprey Daylite and Transporter expandable travel packs driving consumer-relevant innovation and POS momentum
  • OXO expansion into high-growth pet category (feeding bowls, stands, mats, storage solutions) to capture incremental demand
  • Braun blood pressure monitors launched in mass channels outperforming plan and gaining share at the world’s largest U.S. mass retailer
  • Olive & June Star Wars: The Mandalorian and Grogu collaboration boosting consumer engagement and collectibles demand
  • Hydro Flask growth supported by expanded retail distribution, inventory optimization, and e-commerce momentum
  • Wellness portfolio outperformance across Braun, Vicks, Honeywell, and PUR, lapping prior tariff-related disruption and benefiting from expanded distribution

Business Development

  • Prime Day timing impact (earlier timing) contributing to favorable Q1 order phasing
  • Olive & June collaboration with Star Wars: The Mandalorian and Grogu
  • Braun blood pressure monitors gaining share at a major U.S. mass retailer (identified as the world’s largest mass retailer)

AI IconFinancial Highlights

  • Net sales +8.2% vs expectations; Q1 benefited from ~$4m–$5m favorable order phasing from earlier Prime Day timing
  • Consolidated gross profit margin decreased 110 bps to 46%, driven by net tariff impact, less favorable inventory obsolescence YoY, and unfavorable home/outdoor customer mix
  • Adjusted operating margin decreased 30 bps to 4%, reflecting tariffs and higher org/go-to-market investment, partially offset by lower outbound freight and favorable operating leverage
  • SG&A ratio decreased to 31% from 45.1% YoY, primarily due to ~$55m pre-tax gain from sale of a distribution facility (April), partly offset by higher people investments
  • Adjusted EPS ahead of expectations supported by ~$1.8m pre-tax benefit from phase one tariff refunds estimated collectible at quarter-end
  • Full-year gross margin compression expected to be heaviest in Q1 as tariff rates cycle through COGS; no future tariff refund phases assumed in base plan

AI IconCapital Funding

  • Debt reduced by $716m using proceeds from the distribution facility sale; net leverage fell to 3.48x from 3.87x
  • Free cash flow slightly negative in the quarter due to tariff payments, annual incentive compensation, and higher cash taxes
  • Full-year free cash flow guidance maintained at $85m–$100m; planned capex range increased by $2m (from management statement)

AI IconStrategy & Ops

  • Operating model reshaped: five dedicated segment general managers with full ownership of brand portfolios (strategy, innovation, commercial execution, business results)
  • Formalized three geo general manager roles to accelerate brand development beyond North America
  • Pricing discipline: previously implemented pricing actions largely holding; ongoing monitoring of retailer/consumer elasticity where higher than expected
  • E-commerce focus: improved channel/pricing alignment and addressing third-party sellers to strengthen consistency; enhancing digital shelf and retail media effectiveness
  • Demand planning early-stage build of a more connected forecasting approach linking demand signals, promotions, and inventory decisions
  • Supply chain changes: building how to make/move product globally; investing in an agile hybrid go-to-market for international via local partners plus direct consumer engagement

AI IconMarket Outlook

  • Raising full-year net sales to $1.759b–$1.831b (home & outdoor $859m–$884m; beauty & wellness $900m–$947m)
  • Maintaining full-year adjusted EBITDA at $190m–$197m (+2.1%–+6.3% YoY)
  • Maintaining full-year adjusted EPS at $3.25–$3.75
  • Maintaining full-year free cash flow at $85m–$100m; quarterly cadence: low-to-mid single digit YoY sales growth in first half; low single-digit decline in second half (midpoint referenced in Q&A)
  • Full-year adjusted EPS phasing: expects ~20% of annual adjusted EPS in first half (with ~15% in Q2), driven by people/brand investment timing and tariff costs cycling into COGS
  • Phase II tariff claims process: phase II tariff refunds announced June 29; company will file claims and incorporate later only with sufficient clarity on timing/collectability

AI IconRisks & Headwinds

  • Tariffs and tariff cost cycling: expected most year-over-year gross margin compression in Q1 as higher rates cycle through COGS; no future refund phases assumed
  • Heightened geopolitical and supply chain disruption (including Middle East conflict) increasing inbound/outbound freight and costs to secure goods; supply risk modeled as a conservative point-in-time estimate
  • Inflationary pressure from commodity input increases and unfavorable Chinese yuan fluctuations; overall cost inflation expected to exceed the $9.2m pre-tax benefit already captured
  • Softer and more selective discretionary demand; cautious retailer behavior; elevated promotional intensity
  • Pricing elasticity risk: elasticity higher than expected in select areas requiring ongoing retailer/consumer response monitoring

Q&A: Analyst Interest

  • Tariff refund timing and cadence: Management said phase one has ~$7m remaining and expects the bulk collected in Q2, while phase II claims are not yet submitted. They expect benefits spread over multiple quarters and potentially into fiscal 2028, avoiding concentration that would hinder reinvestment alignment.
  • Revenue outlook conservatism vs supply risk line-of-sight: Management quantified pull-forward impact (beat expectations by ~$25m in Q1, with ~$5m pulled into Q2) and left ~$15m potential supply risk. They described pinch points, volatility, and increased disruption risk after events ā€œlast night,ā€ but still with some visibility.
  • Pricing, promotion, and margin phasing confidence: Management stated ~80% of targeted pricing was passed through across brands/categories and monitors competition and retailer response for adjustments. They cited divergence between dollar share and POS growth in areas with unit softness, tied to embedded elasticity assumptions and ongoing unit-level monitoring.

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the HELE Q1 2027 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

šŸ“‹ Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for HELE.

SEC EDGAR Live Feed
Loading financial data and tables...
šŸ“

SEC Filings (HELE)

Ā© 2026 Stock Market Info — Helen of Troy Limited (HELE) Financial Profile